Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer

Cancer Res. 2020 May 15;80(10):2072. doi: 10.1158/0008-5472.CAN-20-0768.
No abstract available

Publication types

  • Published Erratum